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Simino et al., page 24
Elevated blood pressure is a well-known risk factor for heart
attack, stroke, and metabolic syndrome, andmuch effort is
devoted to the prevention, detection, and treatment of
hypertension. Although age is known to play a large role
in cardiovascular health, the interplay between age and
the genetic architecture of blood pressure regulation has
remained largely unexplored. Now, postulating that the
variants that confer risk to early-onset hypertension might
differ from those that influence onset later in life, Simino
et al. present the results of genome-wide association
studies (GWASs) that combined age stratification and
meta-regression. Notably, the authors identified loci that
exhibit age-dependent effects on blood pressure. One of
these loci is EHBP1L1, whose discovery was entirely depen-
dent upon stratifying individuals on the basis of age. These
findings should provide insight into the biology that
underlies blood pressure regulation in different age groups,
perhaps aiding in the development of new treatment
strategies. More broadly, these results provide proof of
principle that age-stratification strategies might improve
the power of GWASs to uncover variants that influence a
broad range of complex traits.Transposable Elements Rewire Human Regulatory
Networks
Marnetto et al., page 39
The dramatic differences seen between humans and chim-
panzees, despite the relative similarity in their genomes,
implies that factors other than variation in protein-coding
genes are important for differentiating one species from
another. One such factor is gene expression, where varia-
tion in regulatory regions might explain some species-
specific differences. To investigate the role that variation
in regulatory regions might play in human evolution, Mar-
netto et al. identified sequences that are human specific
and also carry chromatin marks indicative of regulatory re-
gions. As a whole, human-specific promoters appear to
have more variation and human-specific enhancers seem
to have less variation than conserved sequences across spe-
cies, suggesting differences in selection. Additionally, these
regions are enriched in DNase hypersensitive sites and spe-
cific transcription factor binding. Supporting the idea that1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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targets of these regulatory regions are enriched with genes
involved in neural processes and development. One poten-
tial source of this de novo variation might be transposable
elements, and in fact, some transposable elements
commonly overlap these regulatory regions. The contrast
between the strong functional associations and the weak
selective pressures and the association of transposable
elements support the idea that regulatory networks are
frequently modified by whole regulatory sequences rather
than subsequent modification at the individual nucleotide
level.Most Genetics Professionals Support the Return of
Incidental Findings
Yu et al., page 77
The return of incidental findings (IFs) to individuals
undergoing exome and whole-genome sequencing is a
controversial issue. It is unclear which results, if any,
should be returned to individuals, which individuals
should receive this information, and how it should be
delivered. Although recommendations have been sug-
gested, it is uncertain howwell these guidelines are aligned
with the opinions of many working genetics professionals,
includingmedical geneticists and genetic counselors, grap-
pling with these issues in the clinical setting. To gather in-
formation from the perspective of genetics professionals,
Yu et al. evaluated 760 completed surveys from members
of the American Society of Human Genetics and the Amer-
ican College of Medical Genetics. From these responses, it
was clear that most genetics professionals supported re-
turning IFs to adults seeking medical care, healthy adults,
and parents of children with a medical condition and
agreed that the decision to return IFs should be based on
individual preference. Many genetics professionals also
supported returning IFs about adult-onset conditions and
carrier status to the parents of a child who has undergone
exome or whole-genome sequencing. Moreover, about half
of the respondents felt that returned IFs should not be
limited to clinically actionable findings. Genetics profes-
sionals strongly supported the idea that the return of IFs
should be in a face-to-face meeting or a phone call with a
genetic counselor, highlighting the importance of individ-
ual interaction in this process, although the time and
training required for delivering the results was also seeny of Human Genetics. All rights reserved.
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as the biggest hurdle to this process. As stakeholders’ opin-
ions are collected and analyzed, it will be noteworthy to
see how changes in policies regarding the return of IFs
unfold.The Rare and the Restless
Schulte et al., page 85
Restless leg syndrome (RLS) is a common neurologic condi-
tion affecting up to ~10% of those with European ancestry.
Typified by the urge to move one’s legs, the disorder is
often accompanied by insomnia and other quality-of-life
issues. Genome-wide association studies have identified
several loci associated with RLS susceptibility, but together,
these explain only a fraction of the estimated heritability.
A better understanding of the underlying causes of RLS
could lead to the development of improved treatment
options. In this issue, Schulte et al. provide an in-depth
exploration of several genes previously linked to RLS and
point toward a key role for loss-of-function variants in
MEIS1, a gene with a known role in neurogenesis. The
authors identified an enrichment of MEIS1 rare variants
in RLS and explored the functional significance of these
alleles in zebrafish experiments. Notably, aberrant pheno-
types were restricted to variants in a single MEIS1 isoform,
suggesting a potential focus for future work aimed at better
understanding the biological underpinnings of this disor-
der. Together with results from recent studies of other com-
plex disorders, these new findings lend increasing support2 The American Journal of Human Genetics 95, 1–2, July 3, 2014to the idea that allelic series of variants—of varying fre-
quency and effect size—underlie the genetic basis for
many complex traits.The End of the (Production) Line
Rowsey et al., page 108
Affecting as many as 20%–40% of all human pregnancies,
aneuploidy is the leading cause of pregnancy loss and birth
defects. Although advanced maternal age is the best-stud-
ied risk factor, the reason(s) underlying this age effect
remain incompletely understood. The ‘‘production-line
model,’’ a prevailing hypothesis in the field, posits that
the first oocytes to enter meiosis will be the first ovulated
and will undergo the highest number of recombination
events. By extension, then, nondisjunction risk, due to
low numbers of crossover events, is highest in oocytes
that undergo late ovulation. Now, through the study of
meiotic recombination in over 8,000 fetal oocytes, Rowsey
et al. challenge this model. Their work fails to establish a
relationship between gestational age and recombination
levels, thus refuting a central tenet of the production-line
model. Notably, the authors did find a remarkable
amount of variation in recombination levels across sam-
ples, suggesting that in-depth analyses on a genome-wide
scale, in conjunction with cell and molecular biology
experiments, might uncover the underpinnings of this
variation, thus providing much-needed insight into why
aneuploidy is so much more common in older mothers.
